Dopamine	O
regulates	O
phosphorylation	O
of	O
VEGF	O
receptor	O
2	O
by	O
engaging	O
Src	O
-	O
homology	O
-	O
2	O
-	O
domain	O
-	O
containing	O
protein	O
tyrosine	O
phosphatase	O
2	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
-	O
induced	O
receptor	O
phosphorylation	O
is	O
the	O
crucial	O
step	O
for	O
initiating	O
downstream	O
signaling	O
pathways	O
that	O
lead	O
to	O
angiogenesis	O
or	O
related	O
pathophysiological	O
outcomes	O
.	O

Our	O
previous	O
studies	O
have	O
shown	O
that	O
the	O
neurotransmitter	O
dopamine	O
could	O
inhibit	O
VEGF	O
-	O
induced	O
phosphorylation	O
of	O
VEGF	O
receptor	O
2	O
(	O
VEGFR	O
-	O
2	O
)	O
,	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
,	O
migration	O
,	O
microvascular	B-Tissue
permeability	O
,	O
and	O
thus	O
,	O
angiogenesis	O
.	O

In	O
this	O
study	O
,	O
we	O
address	O
the	O
mechanism	O
by	O
which	O
VEGFR	O
-	O
2	O
phosphorylation	O
is	O
regulated	O
by	O
dopamine	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
D2	O
dopamine	O
receptor	O
(	O
D2DR	O
)	O
colocalizes	O
with	O
VEGFR	O
-	O
2	O
at	O
the	O
cell	B-Cellular_component
surface	I-Cellular_component
.	O

Dopamine	O
pretreatment	O
increases	O
the	O
translocation	O
and	O
colocalization	O
of	O
Src	O
-	O
homology	O
-	O
2	O
-	O
domain	O
-	O
containing	O
protein	O
tyrosine	O
phosphatase	O
(	O
SHP	O
-	O
2	O
)	O
with	O
D2DR	O
at	O
the	O
cell	B-Cellular_component
surface	I-Cellular_component
.	O

Dopamine	O
administration	O
leads	O
to	O
increased	O
VEGF	O
-	O
induced	O
phosphorylation	O
of	O
SHP	O
-	O
2	O
and	O
this	O
increased	O
phosphorylation	O
parallels	O
the	O
increased	O
phosphatase	O
activity	O
of	O
SHP	O
-	O
2	O
.	O

Active	O
SHP	O
-	O
2	O
then	O
dephosphorylates	O
VEGFR	O
-	O
2	O
at	O
Y951	O
,	O
Y996	O
and	O
Y1059	O
,	O
but	O
not	O
Y1175	O
.	O

We	O
also	O
observe	O
that	O
SHP	O
-	O
2	O
knockdown	O
impairs	O
the	O
dopamine	O
-	O
regulated	O
inhibition	O
of	O
VEGF	O
-	O
induced	O
phosphorylation	O
of	O
VEGFR	O
-	O
2	O
and	O
,	O
subsequently	O
,	O
Src	O
phosphorylation	O
and	O
migration	O
.	O

Our	O
data	O
establish	O
a	O
novel	O
role	O
for	O
SHP	O
-	O
2	O
phosphatase	O
in	O
the	O
dopamine	O
-	O
mediated	O
regulation	O
of	O
VEGFR	O
-	O
2	O
phosphorylation	O
.	O

